Salt Lake City, UT (May 29, 2018) — Earlier today, the Lt. Governor issued formal certification of the Utah Medical Cannabis Act for November’s ballot. The following statement was subsequently issued by Connor Boyack, president of Libertas Institute:
“Today’s announcement is victory for patients and their supporters—including our organization—who have worked hard for years to make sure Utah law does not treat patients as criminals.
“While the Legislature has only been willing to support incremental steps that help few patients, the public has consistently been willing to support a broader program that helps thousands of sick and suffering Utahns find the relief they and their physicians believe cannabis might offer.
“We are pleased to learn that our opposition’s shady tactics to remove signatures and mislead the public about what’s in the Utah Medical Cannabis Act were unsuccessful. We respect those with differing opinions, but believe it’s time for Utah voters to take the issue into their own hands and change this unjust law that criminalizes our loved ones and neighbors.”
Libertas Institute has been intimately involved in medical cannabis policy in Utah since before the Legislature first considered “Charlee’s Law” in 2014, which legalized CBD oil for certain epileptic patients.
